High-Dose Radiotherapy for Non-Small Cell Lung Cancer
Author Information
Author(s): Uitterhoeve Apollonia LJ, Koolen Mia GJ, van Os Rob M, Koedooder Kees, van de Kar Marlou, Pieters Bradley R, Koning Caro CE
Primary Institution: Academic Medical Center/University of Amsterdam
Hypothesis
Is high-dose radiotherapy combined with chemotherapy effective for patients with Non-Small Cell Lung Cancer?
Conclusion
High-dose radiotherapy combined with either concomitant or sequential chemotherapy is effective for patients with locally advanced Non-Small Cell Lung Cancer.
Supporting Evidence
- The 1, 2, and 5 year overall survival rates were 46%, 24%, and 15%, respectively.
- Chemo-radiation significantly improved overall survival compared to radiotherapy alone.
- Local recurrence was observed in 36% of patients, and distant metastases in 46%.
Takeaway
Doctors found that giving a strong dose of radiation along with some medicines helps people with a type of lung cancer called Non-Small Cell Lung Cancer live longer.
Methodology
The study analyzed treatment outcomes of 131 patients with inoperable Non-Small Cell Lung Cancer who received high-dose radiotherapy with or without chemotherapy from 1995 to 2004.
Potential Biases
Potential selection bias due to the non-randomized nature of the study.
Limitations
The study is retrospective and lacks randomization, which may introduce selection bias.
Participant Demographics
Mean age was 66 years, with a range from 30 to 85 years; 89 males and 42 females.
Statistical Information
P-Value
0.024
Confidence Interval
95% CI 10.7 to 16.1
Statistical Significance
p=0.024
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website